These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25459142)

  • 21. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
    Bauersachs R; Kuhl H; Lindhoff-Last E; Ehrly AM
    Vasa; 1996; 25(3):209-20. PubMed ID: 8967151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States.
    Levy SE; Giarelli E; Lee LC; Schieve LA; Kirby RS; Cunniff C; Nicholas J; Reaven J; Rice CE
    J Dev Behav Pediatr; 2010 May; 31(4):267-75. PubMed ID: 20431403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Substitution for Intellectual Disability: A Flawed Explanation for the Rise in Autism.
    Nevison CD; Blaxill M
    J Autism Dev Disord; 2017 Sep; 47(9):2733-2742. PubMed ID: 28589495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition.
    Mandy W; Lai MC
    J Child Psychol Psychiatry; 2016 Mar; 57(3):271-92. PubMed ID: 26782158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief Report: Estimated Prevalence of a Community Diagnosis of Autism Spectrum Disorder by Age 4 Years in Children from Selected Areas in the United States in 2010: Evaluation of Birth Cohort Effects.
    Soke GN; Maenner MJ; Christensen D; Kurzius-Spencer M; Schieve LA
    J Autism Dev Disord; 2017 Jun; 47(6):1917-1922. PubMed ID: 28342162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and the risk of ductal breast carcinoma in situ.
    Claus EB; Stowe M; Carter D
    Breast Cancer Res Treat; 2003 Sep; 81(2):129-36. PubMed ID: 14572155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Changing Epidemiology of Autism Spectrum Disorders.
    Lyall K; Croen L; Daniels J; Fallin MD; Ladd-Acosta C; Lee BK; Park BY; Snyder NW; Schendel D; Volk H; Windham GC; Newschaffer C
    Annu Rev Public Health; 2017 Mar; 38():81-102. PubMed ID: 28068486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives and the risk of myocardial infarction.
    Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
    N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.